An interventional study of Alcohol health harm message exposure in Alcohol, Message Perception and PME, sponsored by University of Connecticut. Not yet recruiting. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by University of Connecticut · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Alcohol increases the risk for at least seven cancers, yet recent estimates suggest only between one-third and one-half of US adults are aware of this risk. The current study aims to develop and test alcohol-cancer messages designed for a mass media public health campaign. The messages will be informed by theory-based constructs proximal to health behavior change (e.g., perceived likelihood/severity of harm, response efficacy). We will evaluate messages via an online, cross-sectional message testing randomized experiment. Participants will be US adults aged 21+ recruited from Qualtrics Panels.
Rational:
Alcohol increases the risk for at least seven cancers, yet recent estimates suggest only between one-third and one-half of US adults are aware of this risk. Raising public awareness of the alcohol-cancer link can encourage better informed choices about alcohol and promote reduced consumption, yet the most effective strategies for raising such awareness remain to be determined.
One potential strategy is the use of alcohol-cancer risk messages, which could be disseminated through various communication channels (e.g., public service announcements, communication campaigns). However, such messages can differ in numerous ways, including their substantive content and the specific language used to communicate risk, and the optimal design of these messages and their effects on audiences remains to be determined.
Ours and others' prior work has tested different alcohol-cancer warning label messages in experimental studies. These experiments have tested the effects of using causal vs. hedging language, the utility of adding pictograms in warning labels, different ways to frame the alcohol-cancer risk relationship, and the type of cancer to communicate in warning labels. The overarching goal of these studies was to develop effective warning labels that could be added to alcohol beverages.
The current study aims to extend this work by developing and preliminarily evaluating alcohol-cancer messages designed for a mass media public health campaign. These messages will be informed by theory-based constructs proximal to health behavior change (e.g., perceived likelihood/severity of harm, response efficacy). We will evaluate messages via an online, cross-sectional message testing randomized experiment. Participants will be US adults aged 21+ recruited from Qualtrics Panels.
Objective:
The primary objective of this study is to identify how different alcohol-cancer message frames affect message-related perceptions and related health outcomes (e.g., perceived message effectiveness, risk beliefs, drinking intentions). Findings will help inform future alcohol harm reduction health communication efforts.
Guiding research question:
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's planned enrollment of 1,400 is above the median of 60 across 7,716 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →University of Connecticut is the lead sponsor of 136 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- none beyond failure to meet the inclusion criteria.
Exposure to two alcohol-cancer messages that convey the probability of experiencing a health harm (i.e., cancer) from a particular hazard (i.e., drinking alcohol). The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Exposure to two alcohol-cancer messages that encourage reducing how much alcohol people drink. The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Exposure to two alcohol-cancer messages that convey how serious getting alcohol-associated cancer will be. The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Exposure to two alcohol-cancer messages that emphasize the effectiveness of protective behaviors for reducing alcohol-associated cancer risk. The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Exposure to two alcohol-cancer messages that emphasize completely abstaining from drinking alcohol. The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Exposure to two alcohol-cancer messages that do not discuss alcohol-associated cancer risk. Instead, the messages use language from the existing U.S. Surgeon General's warning on alcoholic beverages. The intervention will be administered in an online survey experiment as static images displayed to participants.
Behavioral: Alcohol health harm message exposure
Participants randomized to control will not be exposed to any message stimuli.
Randomized exposure to one of five alcohol-cancer health campaign message frames, or a non-cancer alcohol harms frame.
Perceived message effectiveness - effects perceptions
A 3-item scale adapted from prior effects perception PME and substance use literature. After each message exposure, participants will be asked to respond to the following items: 1) This message discourages me from wanting to drink alcohol; 2) This message makes me concerned about the health effects of drinking alcohol; and 3) This message makes drinking alcohol seem unpleasant to me. Items will be assessed on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). We will assess internal consistency using Cronbach's alpha. Assuming adequate measure reliability, we will average the items into a single composite PME measure.
Time frame: Day 1; post intervention exposure
Drinking intentions
Intentions will be assessed with a 3-item scale adapted from prior substance use and health communication research. Participants will answer each of the following questions: How likely is it that you will drink alcohol in the... 1) next week, 2) next month, and 3) next year. Responses will be on 5-point scales ranging from "not at all" (1) to "extremely" (5). We will assess internal consistency using Cronbach's alpha. Assuming adequate measure reliability, we will average the items into a single composite measure.
Time frame: Day 1; post intervention exposure
Message reactance
Message reactance will be assessed with a brief 3-item scale used in prior research. Participants will respond to the following statements: 1) This message is trying to manipulate me, 2) The health effect in this message is overblown, and 3) This message annoys me. Responses will be assessed on 5-point scales ranging from "strongly disagree" (1) to "strongly agree" (5). We will assess internal consistency using Cronbach's alpha. Assuming adequate measure reliability, we will average the items into a single composite measure.
Time frame: Day 1; post intervention exposure
Non-alcoholic beer message perceptions
A single item that has participants respond to the following statement: "This message makes me think drinking non-alcoholic beer is healthier than alcoholic beer." This item will be assessed on a 5-point scale ranging from strongly disagree (1) to strongly agree (5).
Time frame: Day 1; post intervention exposure
Perceived message effectiveness - message perceptions
A 5-item scale assessing perceptions of each message, adapted from prior work. After each message exposure, participants will respond to the following items: 1) "This message grabs my attention"; 2) "This message is believable"; 3) "This message is credible"; 4) "This message is trustworthy"; and 5) "I learned something new from this message." Items will be assessed on a 5-point scale ranging from strongly disagree (1) to strongly agree (5). We will assess internal consistency using Cronbach's alpha. Assuming adequate measure reliability, we will average the items into a single composite measure.
Time frame: Day 1; post intervention exposure
Attitudes toward alcohol
A 3-item measure assessing attitudes toward drinking alcohol. Participants will rate drinking alcohol on three 5-point bipolar scales: 1) harmful/safe; 2) bad/good; and 3) unhealthy/healthy. We will assess internal consistency using Cronbach's alpha. Assuming adequate reliability, we will average the items into a single composite attitude measure.
Time frame: Day 1; post intervention exposure
Intentions to reduce alcohol use
Assessed only among participants who currently drink alcohol. Participants will be asked, "How likely are you to reduce how much alcohol you drink?" Responses will be assessed on a 5-point scale ranging from not at all (1) to very much (5).
Time frame: Day 1; post intervention exposure
Alcohol-cancer causal beliefs
Causal beliefs will be assessed with a single item: "How likely do you think it is that alcohol causes cancer?" Responses will be assessed on a 5-point scale ranging from not at all (1) to very much (5).
Time frame: Day 1; post intervention exposure
Intentions to quit drinking alcohol
Participants who currently drink alcohol will be asked, "How likely are you to quit drinking alcohol?" Responses will be assessed on a 5-point scale ranging from not at all (1) to very much (5).
Time frame: Day 1; post intervention exposure
Alcohol-cancer risk beliefs
We will assess risk beliefs using a 3-item scale assessing affective, experiential, and deliberative perceptions of cancer risk among participants who currently drink alcohol. The measure stem will state, "If you continue to drink alcohol at your current level…" Participants will then answer the following items: 1) "How worried are you about eventually getting cancer?"; 2) "To what extent could you see yourself eventually getting cancer?"; and 3) "How likely do you think it is that you will eventually get cancer?" Items will be assessed on a 5-point scale ranging from not at all (1) to very much (5). We will assess these items separately, as they tap into different tri-risk constructs; however, for exploratory purposes we will also assess internal consistency of the three items using Cronbach's alpha. Assuming adequate reliability, we will average the items into a single composite measure.
Time frame: Day 1; post intervention exposure
Support for message on alcohol containers
Assessed with a single item: "I believe a message like this should be added to alcohol beverage containers." Responses will be assessed on a 5-point scale ranging from strongly disagree (1) to strongly agree (5).
Time frame: Day 1; post intervention exposure
Perceived effectiveness of message on alcohol containers
Assessed with a single item: "Seeing a message like this on an alcoholic beverage would make me think twice about drinking alcohol." Responses will be assessed on a 5-point scale ranging from strongly disagree (1) to strongly agree (5).
Time frame: Day 1; post intervention exposure
No study locations are listed for this record.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — We will share anonymized IPD with researchers upon reasonable request to the project Principal Investigator.
Time frame: IPD will be available on an ad hoc basis upon reasonable request for at least three years after the experiment is completed.
Access criteria: Other researchers who provide a reasonable request about how they will use the data (e.g., validation, secondary analyses, etc).
Start is estimated for Sep 2026; primary completion for Oct 2026, 1 month later.
Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 1 month is below that.
Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.